Cetacaine-induced acute methemoglobinemia.
Ferraro
L
L
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York 10021.
Zeichner
S
S
Greenblott
G
G
Groeger
J S
JS
D010129:4-Aminobenzoic Acid / Q000009:adverse effects*; D000208:Acute Disease; D000368:Aged; D062365:Aminobenzoates / Q000009:adverse effects*; D001548:Benzalkonium Compounds / Q000009:adverse effects*; D001566:Benzocaine / Q000009:adverse effects*; D002593:Cetrimonium Compounds / Q000009:adverse effects*; D003490:Cyanosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D008708:Methemoglobinemia / Q000139:chemically induced* / Q000150:complications; D008751:Methylene Blue / Q000627:therapeutic use; D010092:Oximetry; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects*; D012121:Respiration, Artificial; D013748:Tetracaine / Q000009:adverse effects*; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D001548:Benzalkonium Compounds; D002593:Cetrimonium Compounds; D004338:Drug Combinations; D000644:Quaternary Ammonium Compounds; C010071:benzocaine, butyl aminobenzoate, tetracaine drug combination; D062366:para-Aminobenzoates; D013748:Tetracaine; D008751:Methylene Blue; D010129:4-Aminobenzoic Acid; D001566:Benzocaine